UK Markets open in 2 hrs 10 mins

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4300+0.0300 (+2.14%)
At close: 04:00PM EST
1.4700 +0.04 (+2.80%)
After hours: 05:48PM EST
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 34.7110
52-week low 31.2700
50-day moving average 31.7778
200-day moving average 32.6002

Share statistics

Avg vol (3-month) 3880.52k
Avg vol (10-day) 3727.55k
Shares outstanding 5108.9M
Implied shares outstanding 6N/A
Float 837.46M
% held by insiders 10.24%
% held by institutions 182.71%
Shares short (14 Dec 2021) 45.47M
Short ratio (14 Dec 2021) 44.97
Short % of float (14 Dec 2021) 4N/A
Short % of shares outstanding (14 Dec 2021) 45.02%
Shares short (prior month 14 Nov 2021) 410.08M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin -73.83%
Operating margin (ttm)-57.82%

Management effectiveness

Return on assets (ttm)-10.35%
Return on equity (ttm)-51.32%

Income statement

Revenue (ttm)36.46M
Revenue per share (ttm)0.35
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -22.01M
Net income avi to common (ttm)-26.92M
Diluted EPS (ttm)-0.3560
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)110.09M
Total cash per share (mrq)1.11
Total debt (mrq)20.61M
Total debt/equity (mrq)25.54
Current ratio (mrq)12.19
Book value per share (mrq)0.82

Cash flow statement

Operating cash flow (ttm)-7.28M
Levered free cash flow (ttm)-12.88M